These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2253209)

  • 21. [Successful treatment with a small dose of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in a case of chronic myelomonocytic leukemia in blastic crisis].
    Tsukada J; Misago M; Sato T; Kikuchi M; Nakata K; Nagata K; Mori N; Otani H; Oda S; Chiba S
    Rinsho Ketsueki; 1989 Jan; 30(1):61-6. PubMed ID: 2716200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the lethal effects in culture of cytosine arabinoside and arabinofuranosyl-5-azacytosine acting on the blast cells fo acute myeloblastic leukemia.
    Yang GS; McCulloch EA
    Hematol Pathol; 1992; 6(3):125-30. PubMed ID: 1385380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of stem cell factor (SCF) on the in vitro growth of leukemic blast progenitors in acute non-lymphocytic leukemia.
    Nara N; Tanikawa S; Nagata K; Hamaguchi H; Tomiyama J
    Int J Hematol; 1993 Aug; 58(1-2):27-35. PubMed ID: 7693028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth modulation and differentiation of acute myeloid leukemia cells by jaspamide.
    Fabian I; Shur I; Bleiberg I; Rudi A; Kashman Y; Lishner M
    Exp Hematol; 1995 Jul; 23(7):583-7. PubMed ID: 7601248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukemia patients by site-selective 8-chloroadenosine 3',5'-cyclic monophosphate.
    Pinto A; Aldinucci D; Gattei V; Zagonel V; Tortora G; Budillon A; Cho-Chung YS
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8884-8. PubMed ID: 1329084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of growth potentiating factor(s) for autologous blast cells by acute myeloblastic leukemia cells.
    Murohashi I; Nagata K; Suzuki T; Yamashita Y; Maruyama Y; Nara N
    Cancer Res; 1988 Nov; 48(22):6424-8. PubMed ID: 3263187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase III study of N4-behenoyl-l-beta-D-arabinofuranosylcytosine in adult acute leukemia-BH-AC-DMP therapy.
    Yamada K; Suzuki H; Kato Y
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec; 43(6):1080-5. PubMed ID: 7331685
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of recombinant human D-factor on the growth of leukemic blast progenitors from acute myeloblastic leukemia patients.
    Chen GJ; Tomida M; Hozumi M; Nara N
    Jpn J Cancer Res; 1992 Dec; 83(12):1341-6. PubMed ID: 1282910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical use of intermediate to high dose of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in children with acute leukemia.
    Takashima Y
    J Clin Pharmacol; 1988 Apr; 28(4):356-62. PubMed ID: 3164731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of platelet-derived growth factor on the proliferation of blast progenitors from acute myeloblastic leukemia patients.
    Nara N; Tohda S; Nagata K; Suzuki T; Yamashita Y; Imai Y
    Acta Haematol; 1990; 83(4):187-92. PubMed ID: 2115715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-renewal capacity of leukemic blast progenitor cells.
    Buick RN; Chang LJ; Messner HA; Curtis JE; McCulloch EA
    Cancer Res; 1981 Nov; 41(11 Pt 2):4849-52. PubMed ID: 6945908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo effects of 5-aza-2'-deoxycytidine (Decitabine) on clonogenic cells from acute myeloid leukemia patients.
    Gattei V; Aldinucci D; Petti MC; Da Ponte A; Zagonel V; Pinto A
    Leukemia; 1993 May; 7 Suppl 1():42-8. PubMed ID: 7683356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokinetic study on the effects of N4-behenoyl-1-beta-D-arabinofuranosylcytosine on murine leukemic cells L 1210: a comparison with the effects of 1-beta-D-arabinofuranosylcytosine.
    Maruo N; Horiuchi H; Nakabo T; Kondo M; Nakamura T
    Hematol Oncol; 1985; 3(1):39-48. PubMed ID: 2580770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemias.
    Karp JE; Passaniti A; Gojo I; Kaufmann S; Bible K; Garimella TS; Greer J; Briel J; Smith BD; Gore SD; Tidwell ML; Ross DD; Wright JJ; Colevas AD; Bauer KS
    Clin Cancer Res; 2005 Dec; 11(23):8403-12. PubMed ID: 16322302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells.
    Gustavsson A; Olofsson T
    Cancer Res; 1984 Oct; 44(10):4648-52. PubMed ID: 6590116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of basic and acidic fibroblast growth factors (bFGF and aFGF) on the growth of leukemic blast progenitors in acute myelogenous leukemia.
    Nara N; Kurokawa H; Tohda S; Tomiyama J; Nagata K; Tanikawa S
    Exp Hematol; 1995 Aug; 23(9):1030-4. PubMed ID: 7543415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug sensitivity test for acute myeloblastic leukemia by an efficient leukemic blast colony assay using 5637-conditioned medium as a stimulator.
    Asano Y; Okamura S; Shibuya T; Morioka E; Harada M; Akazawa K; Niho Y
    J Med; 1990; 21(6):289-99. PubMed ID: 2093096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic and clinical studies of N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
    Yamada K; Kawashima K; Kato Y; Morishima Y; Tanimoto M; Ohno R
    Recent Results Cancer Res; 1980; 70():219-29. PubMed ID: 6766563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of recombinant interferons on colony formation of blast progenitors in acute myeloblastic leukemia.
    Takanashi M; Motoji T; Oshimi K; Mizoguchi H
    Exp Hematol; 1987 Oct; 15(9):946-51. PubMed ID: 2443379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N4-Behenoyl-1-beta-D-arabinofuranosylcytosine as a potential new antitumor agent.
    Aoshima M; Tsukagoshi S; Sakurai Y; Oh-ishi JI; Ishida T
    Cancer Res; 1977 Aug; 37(8 Pt 1):2481-6. PubMed ID: 872077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.